Melissa Baird - 12 May 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Reporting relationship: Chief Operating Officer
Issuer ticker: HIMS
Reported as of: 12 May 2025
Net transaction value: -$1,786,377
SEC form: 4
Accepted by SEC: 13 May 2025, 17:07:27 UTC
Prior SEC filing: 23 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Alexandra Cotter Wilkins, Attorney-in-Fact

Key filing fact

Melissa Baird filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 13 May 2025.

Key facts

This page summarizes Melissa Baird's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
6 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 May 2025, 17:07.

Change

Previous filing in this sequence was filed on 23 Apr 2025.
Current net transaction value: -$1,786,377.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001837815 Primary reporting owner

Baird Melissa

Relationship: Chief Operating Officer
Address: 2269 CHESTNUT STREET, #523, SAN FRANCISCO
Signature: /s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Signature date: 13 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIMS transaction

Class A Common Stock

Options Exercise

Transaction value: $80,999
Shares: +33,333
Change %: +4.1%
Price: $2.43
Shares after: 838,416
Date: 12 May 2025
Ownership: Direct
Footnotes: F1

HIMS transaction

Class A Common Stock

Sale

Transaction value: $757,935
Shares: -13,786
Change %: -1.6%
Price: $54.98
Shares after: 824,630
Date: 12 May 2025
Ownership: Direct
Footnotes: F1, F2

HIMS transaction

Class A Common Stock

Sale

Transaction value: $379,872
Shares: -6,801
Change %: -0.82%
Price: $55.86
Shares after: 817,829
Date: 12 May 2025
Ownership: Direct
Footnotes: F1, F3

HIMS transaction

Class A Common Stock

Sale

Transaction value: $429,210
Shares: -7,556
Change %: -0.92%
Price: $56.80
Shares after: 810,273
Date: 12 May 2025
Ownership: Direct
Footnotes: F1, F4

HIMS transaction

Class A Common Stock

Sale

Transaction value: $300,360
Shares: -5,190
Change %: -0.64%
Price: $57.87
Shares after: 805,083
Date: 12 May 2025
Ownership: Direct
Footnotes: F1, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIMS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -33,333
Change %: -4.6%
Price: $0.000000
Shares after: 693,795
Date: 12 May 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 33,333
Exercise price: $2.43
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

Footnote F2

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F3

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F4

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F5

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F6

Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.